T1	PROC 77 98	oxígeno suplementario
#1	AnnotatorNotes T1	C0919655; Oxygen supplementation; Therapeutic or Preventive Procedure
T2	CHEM 77 84	oxígeno
#2	AnnotatorNotes T2	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T3	DISO 116 151	embolia de pulmón aguda sintomática
#3	AnnotatorNotes T3	C2882221; Acute pulmonary embolism; Disease or Syndrome (?)
T4	PROC 207 238	evaluar la eficacia y seguridad
#4	AnnotatorNotes T4	C0511730; Identify product efficacy and safety issues; Health Care Activity
T5	PROC 252 289	tratamiento con oxígeno suplementario
T6	DISO 307 330	tromboembolia de pulmón
T7	DISO 381 398	Embolia de pulmón
T8	ANAT 392 398	pulmón
#5	AnnotatorNotes T8	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T9	DISO 425 461	Embolismo pulmonar agudo sintomático
T10	PROC 962 988	fórmula de Cockcroft-Gault
#6	AnnotatorNotes T10	C2711451; Estimation of creatinine clearance by Cockcroft-Gault formula; Laboratory Procedure
T11	PROC 728 752	consentimiento informado
#7	AnnotatorNotes T11	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T12	PROC 533 581	angiotomografía computerizada (TC) multidetector
#8	AnnotatorNotes T12	C4763552; Multi-detector Computed Tomography Angiography; Diagnostic Procedure
T13	CHEM 811 829	contrastes iodados
T14	DISO 595 628	Disfunción del ventrículo derecho
#9	AnnotatorNotes T14	C3532832; Dysfunction of right cardiac ventricle; Disease or Syndrome
T15	ANAT 610 628	ventrículo derecho
#10	AnnotatorNotes T15	C0225883; Right ventricular structure; Body Part, Organ, or Organ Component | C1269891; Entire right ventricle; Body Part, Organ, or Organ Component
T16	PROC 636 651	ecocardiografía
#11	AnnotatorNotes T16	C0013516; Echocardiography; Diagnostic Procedure
T17	PROC 695 706	diagnóstico
#12	AnnotatorNotes T17	C0011900; Diagnosis; Diagnostic Procedure
T18	DISO 801 808	Alergia
#13	AnnotatorNotes T18	C1527304; Allergic Reaction; Pathologic Function
T19	DISO 834 853	Insuficiencia renal
#14	AnnotatorNotes T19	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T20	CHEM 878 888	creatinina
#15	AnnotatorNotes T20	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T21	ANAT 889 895	sérica
#16	AnnotatorNotes T21	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T22	PROC 914 940	aclaramiento de creatinina
#17	AnnotatorNotes T22	C0373595; Creatinine clearance measurement; Laboratory Procedure
T23	PROC 1001 1036	oxigenoterapia crónica domiciliaria
T24	DISO 1041 1052	Hipercapnia
#18	AnnotatorNotes T24	C0020440; Hypercapnia; Finding
T25	PROC 1086 1097	diagnóstico
#19	AnnotatorNotes T25	C0011900; Diagnosis; Diagnostic Procedure
T26	PROC 1103 1118	Ecocardiografía
#20	AnnotatorNotes T26	C0013516; Echocardiography; Diagnostic Procedure
T27	PROC 1178 1204	tratamiento anticoagulante
#21	AnnotatorNotes T27	C0150457; Anticoagulant therapy; Therapeutic or Preventive Procedure
T28	DISO 1267 1275	síntomas
#22	AnnotatorNotes T28	C1457887; Symptoms; Sign or Symptom
T29	DISO 1289 1315	Inestabilidad hemodinámica
#23	AnnotatorNotes T29	C0948268; Hemodynamic instability; Disease or Syndrome
T30	CHEM 1368 1386	drogas vasoactivas
T31	PROC 1440 1466	reanimación cardiopulmonar
#24	AnnotatorNotes T31	C0007203; Cardiopulmonary Resuscitation; Therapeutic or Preventive Procedure
T32	PROC 1471 1481	intubación
#25	AnnotatorNotes T32	C0021925; Intubation (procedure); Therapeutic or Preventive Procedure
T33	PROC 1487 1511	tratamiento trombolítico
T34	PROC 1540 1554	ensayo clínico
#26	AnnotatorNotes T34	C0008976; Clinical Trials; Research Activity
T35	PROC 1563 1574	tratamiento
#27	AnnotatorNotes T35	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T36	ANAT 1631 1638	nasales
#28	AnnotatorNotes T36	C0028429; Nose; Body Part, Organ, or Organ Component
T37	ANAT 127 133	pulmón
#29	AnnotatorNotes T37	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T38	PROC 174 201	Ensayo clínico aleatorizado
#30	AnnotatorNotes T38	C0206034; Clinical Trials, Randomized; Research Activity
T39	CHEM 268 275	oxígeno
#31	AnnotatorNotes T39	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T40	ANAT 324 330	pulmón
#32	AnnotatorNotes T40	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T41	DISO 332 335	TEP
#33	AnnotatorNotes T41	C0034065; Pulmonary Embolism; Pathologic Function | C0524702; Pulmonary Thromboembolisms; Disease or Syndrome
T42	ANAT 435 443	pulmonar
#34	AnnotatorNotes T42	C0034052; Pulmonary artery structure; Body Part, Organ, or Organ Component | C1269026; Entire pulmonary artery; Body Part, Organ, or Organ Component
T43	DISO 491 512	TEP aguda sintomática
T44	DISO 710 713	TEP
#35	AnnotatorNotes T44	C0034065; Pulmonary Embolism; Pathologic Function | C0524702; Pulmonary Thromboembolisms; Disease or Syndrome
T45	ANAT 848 853	renal
#36	AnnotatorNotes T45	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T46	PROC 878 895	creatinina sérica
#37	AnnotatorNotes T46	C0201976; Creatinine measurement, serum (procedure); Laboratory Procedure
T47	CHEM 930 940	creatinina
#38	AnnotatorNotes T47	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T48	CHEM 1190 1204	anticoagulante
#39	AnnotatorNotes T48	C0003280; Anticoagulants; Pharmacologic Substance
T49	PROC 1317 1343	tensión arterial sistólica
#40	AnnotatorNotes T49	C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T50	ANAT 1325 1333	arterial
#41	AnnotatorNotes T50	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T51	PROC 1054 1058	pCO2
#42	AnnotatorNotes T51	C0201931; Carbon dioxide measurement, partial pressure; Laboratory Procedure
T52	ANAT 1452 1466	cardiopulmonar
#43	AnnotatorNotes T52	C0553534; Cardiopulmonary; Body Location or Region
T53	CHEM 1499 1511	trombolítico
#44	AnnotatorNotes T53	C0016018; Fibrinolytic Agents; Pharmacologic Substance
T54	DISO 1581 1584	TEP
#45	AnnotatorNotes T54	C0034065; Pulmonary Embolism; Pathologic Function | C0524702; Pulmonary Thromboembolisms; Disease or Syndrome
T55	Date 13 17	2019
T56	LIVB 102 111	pacientes
#46	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	LIVB 293 302	pacientes
#47	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T59	Duration 665 686	las primeras 12 horas
T60	Age 788 796	<18 años
T63	Duration 1016 1023	crónica
#48	AnnotatorNotes T63	C0205191; chronic; Temporal Concept
T64	LIVB 1221 1245	investigador responsable
#49	AnnotatorNotes T64	C4708568; Medically responsible investigator; Professional or Occupational Group
T65	Duration 1276 1284	>10 días
T66	PHYS 1303 1315	hemodinámica
#50	AnnotatorNotes T66	C0019010; Hemodynamics; Organ or Tissue Function
T67	PHYS 1317 1333	tensión arterial
#51	AnnotatorNotes T67	C0005823; Blood Pressure; Organism Function
T69	LIVB 1426 1434	paciente
#52	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T70	Neg_cue 1590 1606	Incapacidad para
T71	DEVI 1612 1622	mascarilla
#53	AnnotatorNotes T71	C0024861; Masks; Medical Device
T72	DEVI 1625 1638	gafas nasales
#54	AnnotatorNotes T72	C0179574; Nasal Cannula; Medical Device
T73	Duration 1671 1679	<90 días
T58	LIVB 1403 1421	médico responsable
#55	AnnotatorNotes T58	C4708568; Medically responsible investigator; Professional or Occupational Group
A1	Assertion T71 Negated
A2	Assertion T72 Negated
A3	Status T18 History_of
A4	Assertion T27 Contraindicated
A5	Assertion T48 Contraindicated
#56	AnnotatorNotes T5	C0919655; Oxygen supplementation; Therapeutic or Preventive Procedure
#57	AnnotatorNotes T6	C0034065; Pulmonary Embolism; Pathologic Function | C0524702; Pulmonary Thromboembolisms; Disease or Syndrome
#58	AnnotatorNotes T7	C0034065; Pulmonary Embolism; Pathologic Function | C0524702; Pulmonary Thromboembolisms; Disease or Syndrome
#59	AnnotatorNotes T30	C0597639; vasoactive agent; Pharmacologic Substance 
#60	AnnotatorNotes T33	C0040044; Thrombolytic Therapy; Therapeutic or Preventive Procedure 
R1	Used_for Arg1:T2 Arg2:T1	
R2	Experiences Arg1:T56 Arg2:T1	
R3	Experiences Arg1:T56 Arg2:T3	
R4	Location_of Arg1:T37 Arg2:T3	
R5	Used_for Arg1:T39 Arg2:T5	
R6	Experiences Arg1:T57 Arg2:T5	
R7	Experiences Arg1:T57 Arg2:T6	
R8	Experiences Arg1:T57 Arg2:T41	
R9	Location_of Arg1:T40 Arg2:T6	
R10	Location_of Arg1:T40 Arg2:T41	
T61	Observation 340 357	riesgo intermedio
#61	AnnotatorNotes T61	C3640764; Intermediate Risk; Finding
R11	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T61	
R12	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T61	
R13	Experiences Arg1:T57 Arg2:T61	
R14	Location_of Arg1:T8 Arg2:T7	
R15	Location_of Arg1:T42 Arg2:T9	
T62	Result_or_Value 582 590	positiva
#62	AnnotatorNotes T62	C1446409; Positive; Finding
R17	Has_Result_or_Value Arg1:T12 Arg2:T62	
R18	Location_of Arg1:T15 Arg2:T14	
R20	Overlap Arg1:T16 Arg2:T59	
R21	After Arg1:T16 Arg2:T17	
R22	Overlap Arg1:T14 Arg2:T44	
R23	Causes Arg1:T13 Arg2:T18	
R24	Location_of Arg1:T45 Arg2:T19	
T68	Quantifier_or_Qualifier 854 859	grave
#63	AnnotatorNotes T68	C1547227; Severe - Severity of Illness Code; Intellectual Product
R25	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T68	
R26	Location_of Arg1:T21 Arg2:T46	
T74	Result_or_Value 896 904	>2 mg/dL
R27	Has_Result_or_Value Arg1:T46 Arg2:T74	
T75	Result_or_Value 941 951	<30 mL/min
R28	Has_Result_or_Value Arg1:T22 Arg2:T75	
R32	Overlap Arg1:T23 Arg2:T63	
T76	Result_or_Value 1059 1067	>50 mmHg
R34	Has_Result_or_Value Arg1:T51 Arg2:T76	
R35	Overlap Arg1:T51 Arg2:T25	
R37	Overlap Arg1:T24 Arg2:T25	
T77	Quantifier_or_Qualifier 1119 1124	basal
#64	AnnotatorNotes T77	C1442488; Baseline; Quantitative Concept
R38	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T77	
T78	Quantifier_or_Qualifier 1138 1148	inadecuada
#65	AnnotatorNotes T78	C0205412; Inadequate (qualifier); Qualitative Concept
R39	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T78	
R40	Used_for Arg1:T48 Arg2:T27	
R41	Has_Duration_or_Interval Arg1:T28 Arg2:T65	
R43	Location_of Arg1:T50 Arg2:T67	
R44	Location_of Arg1:T50 Arg2:T49	
T79	Result_or_Value 1344 1353	<90 mm Hg
R46	Has_Result_or_Value Arg1:T49 Arg2:T79	
R49	Location_of Arg1:T52 Arg2:T31	
R52	Used_for Arg1:T53 Arg2:T33	
R53	Experiences Arg1:T69 Arg2:T29	
R54	Experiences Arg1:T69 Arg2:T67	
R55	Experiences Arg1:T69 Arg2:T49	
R56	Experiences Arg1:T69 Arg2:T30	
R57	Experiences Arg1:T69 Arg2:T31	
R58	Experiences Arg1:T69 Arg2:T32	
R59	Experiences Arg1:T69 Arg2:T33	
T80	Observation 1518 1554	Participación en otro ensayo clínico
R60	Negation Arg1:T70 Arg2:T71	
R61	Negation Arg1:T70 Arg2:T72	
T81	CONC 1644 1661	Esperanza de vida
#66	AnnotatorNotes T81	C0023671; Life Expectancy; Group Attribute
R62	Has_Duration_or_Interval Arg1:T81 Arg2:T73	
#67	AnnotatorNotes T13	C0879373; Iodinated Contrast Agent; Indicator, Reagent, or Diagnostic Aid
R16	Experiences Arg1:T69 Arg2:T66	
#68	AnnotatorNotes T23	C1960973; Home oxygen therapy; Health Care Activity (?)
#69	AnnotatorNotes T9	C2882221; Acute pulmonary embolism; Disease or Syndrome (?)
A6	Experiencer T56 Patient
A7	Experiencer T57 Patient
A8	Experiencer T64 Other
A9	Experiencer T58 Other
A10	Experiencer T69 Patient
